Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Thanks to Our Reviewers in 2022

Thanks to Our Reviewers in 2022 Antibody Therapeutics, 2023, Vol. 6, No. 2 75–75 https://doi.org/10.1093/abt/tbad005 Advance Access Publication on 24 March 2023 Editorial We would like to take this opportunity to express our sincere appreciation for those who reviewed manuscripts for our journal Antibody Therapeutics. The valuable insights and feedback from our reviewers are essential in maintaining the high standards of our journal for serving the scientific community. We recognize that reviewing manuscripts is a demanding task that requires a significant amount of time and effort, and we are truly grateful to the reviewers for their dedication and commitment to this important role. Their generosity in sharing expert knowledge and expertise has been invaluable. We look forward to continued support and collaboration as we work together to advance the field of antibody engineering and therapeutics. The experts listed below, as well as a number of other reviewers who would like to remain anonymous, reviewed manuscripts for Antibody Therapeutics in 2022. Ab, Olga Gui, Xun Pelegri-O’Day, Emma Akiba, Hiroki Gurusamy, Balakrishnan Pirhanov, Azady An, Zhiqiang He, Xin Polson, Andrew G. Angkasekwinai, Pornpimon Hirasawa, Noriyasu Prior, Sandra Antignani, Antonella Huang, He Qiu, Yu Bhatia, Hema Huang, Jian Rader, Christoph Booth, Brian Huang, Lei Rai, Praveen Borth, Nicole Jiang, Weidong Raina, Deepak Carter, Paul Jung, Sang Taek Ratnam, Manohar Chen, Chun Karunasagar, Iddya Rosenthal, Dean Chen, Lei Kathuria, Sagar Sarangapani, Prasad Chen, Xiaocheng Klein, Christian Shen, Guodong Chen, Xin Ku, Sherman Sun, Yaping Chen, Yuanzhi Ku, Zhiqiang Tustian, Andrew Chen, Yuxin Laber, Joshua Vasquez, Maximiliano Chen, Zhoujiang Li, Nan Wang, Ziming Chen, Zirong Li, Shichang Williams, John Cho, Yong Ku Li, Shuqi Xia, Ningshao Chow, Sih-Yao Li, Wei Xu, Jianqing Chuang, Ray Li, Xinxin Yu, Xin Chung, Junho Liu, Dayou Zhan, Jinbiao Feng, Mingqian Liu, Xiaoguang Zhang, Sheng Feng, Zijie Lou, Yang Zhang, Wei FitzGerald, David Ma, Ningning Zhang, Xiao Fort, Madeline Malm, Magdalena Zhang, Xuyao Fu, Ying Meng, Feilong Zhang, Yang Gao, Wenda Morris, Christopher Zhao, Zhihui Gavin, Marc Narhi, Linda Zong, Shuai Ge, Xin O’Mara, Brian Goswami, Arvind Ou, Jianfa © The Author(s) 2023. Published by Oxford University Press on behalf of Antibody Therapeutics. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Antibody Therapeutics Oxford University Press

Thanks to Our Reviewers in 2022

Antibody Therapeutics , Volume 6 (2): 1 – Mar 24, 2023

Loading next page...
 
/lp/oxford-university-press/thanks-to-our-reviewers-in-2022-VkMznPMcEW

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Oxford University Press
Copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Antibody Therapeutics.
eISSN
2516-4236
DOI
10.1093/abt/tbad005
Publisher site
See Article on Publisher Site

Abstract

Antibody Therapeutics, 2023, Vol. 6, No. 2 75–75 https://doi.org/10.1093/abt/tbad005 Advance Access Publication on 24 March 2023 Editorial We would like to take this opportunity to express our sincere appreciation for those who reviewed manuscripts for our journal Antibody Therapeutics. The valuable insights and feedback from our reviewers are essential in maintaining the high standards of our journal for serving the scientific community. We recognize that reviewing manuscripts is a demanding task that requires a significant amount of time and effort, and we are truly grateful to the reviewers for their dedication and commitment to this important role. Their generosity in sharing expert knowledge and expertise has been invaluable. We look forward to continued support and collaboration as we work together to advance the field of antibody engineering and therapeutics. The experts listed below, as well as a number of other reviewers who would like to remain anonymous, reviewed manuscripts for Antibody Therapeutics in 2022. Ab, Olga Gui, Xun Pelegri-O’Day, Emma Akiba, Hiroki Gurusamy, Balakrishnan Pirhanov, Azady An, Zhiqiang He, Xin Polson, Andrew G. Angkasekwinai, Pornpimon Hirasawa, Noriyasu Prior, Sandra Antignani, Antonella Huang, He Qiu, Yu Bhatia, Hema Huang, Jian Rader, Christoph Booth, Brian Huang, Lei Rai, Praveen Borth, Nicole Jiang, Weidong Raina, Deepak Carter, Paul Jung, Sang Taek Ratnam, Manohar Chen, Chun Karunasagar, Iddya Rosenthal, Dean Chen, Lei Kathuria, Sagar Sarangapani, Prasad Chen, Xiaocheng Klein, Christian Shen, Guodong Chen, Xin Ku, Sherman Sun, Yaping Chen, Yuanzhi Ku, Zhiqiang Tustian, Andrew Chen, Yuxin Laber, Joshua Vasquez, Maximiliano Chen, Zhoujiang Li, Nan Wang, Ziming Chen, Zirong Li, Shichang Williams, John Cho, Yong Ku Li, Shuqi Xia, Ningshao Chow, Sih-Yao Li, Wei Xu, Jianqing Chuang, Ray Li, Xinxin Yu, Xin Chung, Junho Liu, Dayou Zhan, Jinbiao Feng, Mingqian Liu, Xiaoguang Zhang, Sheng Feng, Zijie Lou, Yang Zhang, Wei FitzGerald, David Ma, Ningning Zhang, Xiao Fort, Madeline Malm, Magdalena Zhang, Xuyao Fu, Ying Meng, Feilong Zhang, Yang Gao, Wenda Morris, Christopher Zhao, Zhihui Gavin, Marc Narhi, Linda Zong, Shuai Ge, Xin O’Mara, Brian Goswami, Arvind Ou, Jianfa © The Author(s) 2023. Published by Oxford University Press on behalf of Antibody Therapeutics. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Journal

Antibody TherapeuticsOxford University Press

Published: Mar 24, 2023

There are no references for this article.